Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
Amgen
Goethe University
Goethe University
Goethe University
Gruppo Italiano Malattie EMatologiche dell'Adulto
National Cancer Institute (NCI)
Wake Forest University Health Sciences
University of Washington
Washington University School of Medicine
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Schleswig-Holstein
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)